Immune responses to linear epitopes on the PorB protein of Neisseria meningitidis in patients with systemic meningococcal disease

Microbiology

Volumn 142, Issue 9, 1996, Pages 2491-2498

  Delvig, Alexei A ^a   Wedege, Elisabeth ^a   Michaelsen, Terje E ^a   Høiby, E Arne ^a   Brandtzæg, Petter ^b   Rosenqvist, Einar ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

B cell epitope; Neisseria meningitidis; PorB protein; Synthetic peptides; Systemic meningococcal disease

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE; PORIN; SYNTHETIC PEPTIDE;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; SYSTEMIC DISEASE;

MENINGOCOCCUS; NEISSERIA MENINGITIDIS;

EID: 0029768891     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-142-9-2491     Document Type: Article

References (58)

1. Achtman, M., Neibert, M., Crowe, B. A., Strittmatter, W., Kusecek, B., Weyse, E., Walsh, M. J., Slawig, B., Morelli, G., Moll, A. & Blake, M. (1988). Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A. J Exp Med 168, 507-525.
2. Ada, G. L. (1992). Vaccine antigens. In Structure of Antigens, pp. 367-391. Edited by M. H. V. Van Regenmortel. London: CRC Press.
3. Ala'Aldeen, D. A. A., Stevenson, P., Griffiths, E., Gorringe, A. R., Irons, L. I., Robinson, A., Hyde, S. & Borriello, S. P. (1994). Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect Immun 62, 2984-2990.
4. Aoun, L., Lavitola, A., Aubert, G., Prère, M. F., Cremieux, A. C. & Martin, P. M. V. (1988). Human antibody response to the 70-kDa common neisserial antigen in patients and carriers of meningococci or non-pathogenic Neisseria. Ann Inst Pasteur Immunol 139, 203-212.
5. Bash, M. C., Lesiak, K. B., Banks, S. D. & Frasch, C. E. (1995). Analysis of Neisseria meningitidis class 3 outer membrane protein gene variable regions and type identification using genetic techniques. Infect Immun 63, 1484-1490.
6. 32-labelled Escherichia coli and staphylococci by the reticuloendothelial system. J Exp Med 110, 27-48.
7. Bjune, G., Høiby, E. A., Gronnesby, J. K., Arnesen, O., Fredriksen, J. H., Halstensen, A., Holten, E., Lindbak, A.-K., Nøkleby, H., Rosenqvist, E., Solberg, L. K., Closs, O., Eng, J., Freholm, L. O., Lystad, A., Bakketeig, L. S. & Hareide, B. (1991). Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338, 1093-1096.
8. Black, J. R., Black, W. J. & Cannon, J. G. (1985). Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections. J Infect Dis 151, 650-657.
9. Blake, M. S. & Gotschlich, E. C. (1986). Functional and immunological properties of pathogenic neisserial surface proteins. In Bacterial Outer Membranes as Model Systems, pp. 377-400. Edited by M. Inouye. New York: John Wiley.
10. Brandtzæg, P., Kierulf, P., Gaustad, P., Skulberg, A., Bruun, J. N., Halvorsen, S. & Sørensen, E. (1989). Plasma endotoxin as predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159, 195-204.
11. Brooks, G. F., Lammel, C. J., Blake, M. S., Kusecek, B. & Achtman, M. (1992). Antibodies against IgA1 protease are stimulated both by clinical disease and by asymptomatic carriage of serogroup A Neisseria meningitidis. J Infect Dis 166, 1316-1321.
12. Caugant, D. A., Frøholm, L. O., Selander, R. K. & Bøvre, K. (1989). Sulfonamide resistance in Neisseria meningitidis isolates of clones of the ET-5 complex. APMIS 97, 425-428.
13. Caugant, D. A., Høiby, E. A., Magnus, P., Scheel, O., Hoel, T., Bjune, G., Wedege, E., Eng, J. & Frøholm, L. O. (1994). Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 32, 323-330.
14. de Cossio, M. E. F., Ohlin, M., Llano, M., Selander, B., Cruz, S., del Valle, J. & Borrebaeck, C. A. K. (1992). Human monoclonal antibodies against an epitope on the class 5c outer membrane protein common to many pathogenic strains of Neisseria meningitidis. J Infect Dis 166, 1322-1328.
15. Delvig, A., Jahn, S., Kusecek, B., Heckels, J. E., Rosenqvist E., Høiby, E. A., Michaelsen, T. E. & Achtman, M. (1994). A comparison of human and murine monoclonal IgGs specific for the P1.7 PorA protein of Neisseria meningitidis. Mol Immunol 31, 1257-1267.
16. Delvig, A. A., Wedege, E., Caugant D. A., Dalseg, R., Kolberg, J., Achtman, M. & Rosenqvist, E. (1995). A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine. Microbiology 141, 1593-1600.
17. Elkins, C., Carbonetti, N. H., Varela, V. A., Stirewalt, D., Klapper, D. G. & Sparling, P. F. (1992). Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol Microbiol 6, 2617-2628.
18. Feavers, I. M., Suker, J., McKenna, A. J., Heath, A. B. & Maiden, M. C. J. (1992). Molecular analysis of the serotyping antigens of Neisseria meningitidis. Infect Immun 60, 3620-3629.
19. Figueroa, J. E. & Densen, P. (1991). Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4, 359-395.
20. Garred, P., Michaelsen, T. E., Bjune, G., Thiel, S. & Svejgaard, A. (1993). A low serum concentration of mannan-binding protein is not associated with serogroup B or C meningococcal disease. Scand J Immunol 37, 468-470.
21. Geysen, H. M., Meloen, R. H. & Barteling, S. J. (1984). Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA 81, 3998-4002.
22. Gotschlich, E. C., Seiff, M. E., Blake, M. S. & Koomey, M. (1987). Porin protein of Neisseria gonorrhoeae: cloning and gene structure. Proc Natl Acad Sci USA 84, 8135-8139.
23. Griffiss, J. M. (1982). Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model. Rev Infect Dis 4, 159-172.
24. Guttormsen, H.-K., Wetzler, L. M. & Næss, A. (1993). Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease. Infect Immun 61, 4734-4742.
25. Guttormsen, H.-K., Wetzler, L. M. & Solberg, C. O. (1994a). Serum opsonins induced during the course of meningococcal disease correlate with anti-outer membrane protein antibodies. In Proceedings of the Ninth Pathogenic Neisseria Conference, pp. 54-55. Edited by J. S. Evans, S. E. Yost, M. C. J. Maiden & I. M. Feavers. Winchester, UK.
26. Guttormsen, H.-K., Wetzler, L. M. & Solberg, C. O. (1994b). Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease. Infect Immun 62, 1437-1443.
27. Hitchcock, P. J. (1989). Unified nomenclature for pathogenic Neisseria species. Clin Microbiol Rev (Supplement) 2, S64-S65.
28. Høiby, E. A., Bjune, G., Frøholm, L. O., Eng, J., Halstensen, A., Rosenqvist, E., Rønnild, E. & Wedege, E. (1991). The Norwegian meningococcal serogroup B outer membrane vesicle protection trials: case tracing, meningococcal antigen detection and serological diagnosis. NIPH Ann 14, 107-123.
29. Kabat, E. A., Liao, J., Osserman, E. F., Gamian, A., Michon, F. & Jennings, H. J. (1988). The epitope associated with the binding of the capsular polysaccharide of the group B meningococcus and of Escherichia coli K1 to a human monoclonal macroglobulin, IgMNOV. J Exp Med 168, 699-711.
30. van der Ley, P., Heckels, J. E., Virji, M., Hoogerhout, P. & Poolman, J. T. (1991). Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun 59, 2963-2971.
31. Livingston, P. O., Calves, M. J., Helling, F., Zollinger, W. D., Blake, M. S. & Lowell, G. H. (1993). GD3/proteosome vaccines induce consistent IgM antibodies against the ganglioside GD3. Vaccine 11, 1199-1204.
32. Lowell, G. H., Ballou, W. R., Smith, L. F., Wirtz, R. A. & Zollinger, W. D. (1988). Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides. Science 240, 800-802.
33. Maeland, J. A. & Wedege, E. (1989). Serum antibodies to cross-reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease. APMIS 97, 774-780.
34. Mandrell, R. E. & Zollinger, W. D. (1989). Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination. Infect Immun 57, 1590-1598.
35. Mee, B. J., Thomas, H., Cooke, S. J., Lambden, P. R. & Heckels, J. E. (1993). Structural comparison and epitope analysis of outer-membrane protein PIA from strains of Neisseria gonorrhoeae with different serovar specificities. J Gen Microbiol 139, 2613-2620.
36. Melancon Kaplan, J. & Murgita, R. A. (1987). Modulation of the immune system by Neisseria meningitidis. Scand J Immunol 26, 213-221.
37. Meola, A., Delmastro, P., Monaci, P., Luzzago, A., Nicosia, A., Felici, F., Cortese, R. & Galfre, G. (1995). Derivation of vaccines from mimotopes. Immunologic properties of human Hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J Immunol 154, 3162-3172.
38. Moran, E. E., Brandt, B. L. & Zollinger, W. D. (1994). Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria miningitidis to serum bactericidal activity. Infect Immun 62, 5290-5295.
39. Morelli, G., del Valle, J., Lammel, C. J., Pohlner, J., Müller, K., Blake, M., Brooks, G. F., Meyer, T. F., Koumaré, B., Brieske, N. & Achtman, M. (1994). Immunogenicity and evolutionary variability of epitopes within IgA1 protease from serogroup A Neisseria meningitidis. Mol Microbiol 11, 175-187.
40. Orren, A., Warren, R. E., Potter, P. C., Jones, A. M., Lachmann, P. J. & Poolman, J. T. (1992). Antibodies to meningococcal class 1 outer membrane proteins in South African complement-deficient and complement-sufficient subjects. Infect Immun 60, 4510-4516.
41. Poolman, J. T., Hopman, C. T. P. & Zanen, H. C. (1983). Immunogenicity of meningococcal antigens as detected in patient sera. Infect Immun 40, 398-406.
42. + T cell subset alteration. J Allergy Clin Immunol 87, 1115-1120.
43. Raziuddin, S., Mir, N. A., El-Awad, M. E., Telmesani, A. W. & Al-Janadi, M. (1994). γ/δ-T lymphocytes and proinflamatory cytokines in bacterial meningitis. J Allergy Clin Immunol 93, 793-789.
44. Romero, J. D. & Outschoorn, I. M. (1994). Current status of meningococcal group B vaccine candidates: capsular or non-capsular? Clin Microbiol Rev 7, 559-575.
45. Rosenqvist, E., Høiby, E. A., Wedege, E., Kusecek, B. & Achtman, M. (1993). The 5C protein of Neisseria meningitidis is highly immunogenic in humans and stimulates bactericidal antibodies. J Infect Dis 167, 1065-1073.
46. Ross, S. C., Rosenthal, P. J., Berberich, H. M. & Densen, P. (1987). Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals. J Infect Dis 155, 1266-1275.
47. Rothbard, J. B., Fernandez, R. & Schoolnik, G. K. (1984). Strain-specific and common epitopes of gonococcal pili. J Exp Med 160, 208-221.
48. Saukkonen, K., Abdillahi, H., Poolman, J. T. & Leinonen, M. (1987). Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B: 15: P1.16 in infant rat infection model: new prospects for vaccine development. Microb Pathog 3, 261-267.
49. Siber, G. R. (1994). Pneumococcal disease: prospects for a new generation of vaccines. Science 265, 1385-1387.
50. Van Regenmortel, M. H. V. (1992). Molecular dissection of protein antigens. In Structure of Antigens, vol. 1, pp. 1-27. Edited by M. H. V. Van Regenmortel. London: CRC Press.
51. Ward, M. J., Lambden, P. R. & Heckels, J. E. (1992). Sequence analysis and relationships between meningococcal class 3 serotype proteins and other porins from pathogenic and non-pathogenic Neisseria species. FEMS Microbiol Lett 73, 283-289.
52. Wedege, E., Bryn, K. & Frøholm, L. O. (1988). Restoration of antibody binding to blotted meningococcal outer membrane proteins using various detergents. J Immunol Methods 113, 51-59.
53. Wedege, E., Bjune, G., Frøholm, L. O., Høiby, E. A. & Rosenqvist, E. (1991). Immunoblotting studies of vaccinee and patient sera from the Norwegian serogroup B meningococcal vaccination trial. NIPH Ann 14, 183-187.
54. Wetzler, L. M., Blake, M. S. & Gotschlich, E. C. (1988). Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations. J Exp Med 168, 1883-1897.
55. Wiertz, E. J. H. J., Van Gaans-van den Brink, J. A. M., Schreuder, G. M. T. H., Termijtelen, A. A. M., Hoogerhout, P. & Poolman, J. T. (1991). T cell recognition of Neisseria meningitidis class I outer membrane proteins: identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements. J Immunol 147, 2012-2018.
56. Wiertz, E. J. H. J., Van Gaans-van den Brink, J. A. M., Gausepohl, H., Prochnicka-Chalufour, A., Hoogerhout, P. & Poolman, J. T. (1992). Identification of T cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis. J Exp Med 176, 79-86.
57. Wolff, K. & Stern, A. (1991). The class 3 outer membrane protein (PorB) of Neisseria meningitidis: gene sequence and homology to the gonococcal porin PIA. FEMS Microbiol Lett 83, 179-186.
58. Zapata, G. A., Vann, W. F., Rubinstein, Y. & Frasch, C. E. (1992). Identification of variable region differences in Neisseria meningitidis class 3 protein sequences among five group B serotypes. Mol Microbiol 6, 3493-3499.